Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Claudin-18.2 Antibody (9T214) is an antibody targeting Claudin-18.2. Anti-Claudin-18.2 Antibody (9T214) can be used in ELISA,FCM.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μL | $209 | 7-10 days | 7-10 days | |
| 100 μL | $348 | 7-10 days | 7-10 days |
| Description | Anti-Claudin-18.2 Antibody (9T214) is an antibody targeting Claudin-18.2. Anti-Claudin-18.2 Antibody (9T214) can be used in ELISA,FCM. |
| Synonyms | UNQ778/PRO1572, SFTPJ, SFTA5, Claudin 18.2 |
| Ig Type | Human IgG1 |
| Clone | 9T214 |
| Reactivity | Human |
| Verified Activity | 1. Untransfected KATO3 cells surface (green line), transfected Human CLDN18.2 KATO3 stable cells surface (red line) and transfected Human CLDN18.1 NIH-3T3 stable cells surface (blue line) were stained with anti-CLDN18.2 antibody (2µg/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry. 2. The Binding Activity of Human CLDN18.2 with Anti-CLDN18.2 recombinant antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized Human CLDN18.2 at 5 μg/mL can bind Anti-CLDN18.2 recombinant antibody, the EC50 is 6.554-27.87 ng/mL. |
| Application | |
| Recommended Dose | FCM:1:50-1:200. |
| Antibody Type | Monoclonal |
| Construction | Recombinant Antibody |
| Purification | Affinity-chromatography |
| Appearance | Liquid |
| Formulation | Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human Claudin-18.2 Protein |
| Antigen Species | Human |
| Gene Name | CLDN18 |
| Uniprot ID | |
| Biology Area | Signal transduction |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.